Fedratinib Induces Spleen Responses and Reduces Symptom Burden as First-line or Salvage Therapy in Patients with Myeloproliferative Neoplasm-Associated Intermediate- or High-Risk Myelofibrosis (MF) and Low Platelet Counts
Harrison, Claire, Schaap, Nicolaas, Vannucchi, Alessandro, Kiladjian, Jean-Jacques, Passamonti, Francesco, Zweegman, Sonja, Talpaz, Moshe, Verstovsek, Srdan, Gerike, Torsten, Rose, Shelonitda, Zhang,Volume:
19
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.07.374
Date:
September, 2019
File:
PDF, 70 KB
english, 2019